Skip to main content
TipRanks
Go Ultimate75% OFF

Marco Taglietti Insider Profile

11 Followers

Marco Taglietti, Director at Aquestive Therapeutics, holds ― shares in Aquestive Therapeutics (Ticker: AQST), holds 272.07K shares in SCYNEXIS (Ticker: SCYX), holds 6.00K shares in Delcath Systems (Ticker: DCTH).

Marco Taglietti's Trading History

SCYX
SCYNEXIS
Apr 28, 2022CEO, DirectorInformative Buy225.00K$905.99K
DCTH
Delcath Systems
May 08, 2020DirectorUninformative Buy―$128.30K
~FRX
Forest Labs
Jul 03, 2014―Uninformative Sell――
NRXGQ
NephroGenex
―――$0.00
AQST
Aquestive Therapeutics
―Director――

You May Also Like

Marco Taglietti insider profile FAQ

What is the percentage of profitable transactions made by Marco Taglietti?
The percentage of profitable transactions made by Marco Taglietti is 15%.
What is the average return per transaction made by Marco Taglietti?
The average return per transaction made by Marco Taglietti is -28.50%.
What stocks does Marco Taglietti hold?
Marco Taglietti holds: AQST, SCYX, DCTH, NRXGQ, ~FRX stocks.
What was Marco Taglietti's most profitable transaction?
Marco Taglietti’s most profitable transaction was an Informative Buy of SCYX stock on January 2, 2019. The return on the trade was 64.80%.
What is Marco Taglietti's role in Aquestive Therapeutics?
Marco Taglietti's role in Aquestive Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.